Zylö Therapeutics

12:15 PM - 12:30 PM (PDT), Wednesday, June 15, 2022
Zylö is a biotechnology company commercializing a proprietary silica matrix encapsulation platform. We partner with companies to help address topical delivery challenges and enhance bioavailability in pharma and animal health applications.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
South Carolina
Company HQ Country:
United States
Year Founded:
2017
Main Therapeutic Focus:
Lead Product in Development:
Topical nitric oxide for the treatment of erectile dysfunction
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided